EMEA-002628-PIP01-19
Key facts
| Active substance |
Botulinum toxin type A
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0307/2019
|
| PIP number |
EMEA-002628-PIP01-19
|
| Pharmaceutical form(s) |
Powder for solution for injection
|
| Condition(s) / indication(s) |
Prevention of post-operative atrial fibrillation in patients undergoing open-chest cardiac surgery
|
| Route(s) of administration |
Intramuscular use
|
| Contact for public enquiries |
Allergan Pharmaceutical International Limited
E-mail: EU_Reg_Affairs@allergan.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|